Publications

Search our bibliography using the filters on the right-hand side.

Displaying 1 through 14 of 14 publications.

Earnshaw SR, Graham CN, McDade CL, Spears JB, Kessler CM. Factor VIII alloantibody inhibitors: cost analysis of immune tolerance induction vs. prophylaxis and on-demand with bypass treatment. Haemophilia. 2015 May;21(3):310-9. doi: 10.1111/hae.12621

Kruse-Jarres R, Gilsenan AW, Spears J, Kaye JA. Prospective, observational study of plasma-derived factor VIII/von Willebrand factor in immune tolerance induction: the PRISM registry. Haemophilia. 2015 Mar;21(2):e122-4. doi: 10.1111/hae.12590

DiBenedetti DB, Coles TM, Sharma T, Pericleous L, Kulkarni R. Assessing patients' and caregivers' perspectives on stability of factor VIII products for haemophilia A: a web-based study in the United States and Canada. Haemophilia. 2014 Jul;20(4):e296-303. doi: 10.1111/hae.12459

Brown TM, Pashos CL, Joshi AV, Lee WC. The perspective of patients with haemophilia with inhibitors and their care givers: preferences for treatment characteristics. Haemophilia. 2011 May 1;17(3):476-82.

Knight C, Plun-Favreau J, Johal S. An economic model to evaluate the cost-effectiveness of prophylaxis regimens on haemophilia patients with inhibitors. Poster presented at the XXIXth International Congress of the World Federation of Hemophilia; July 2010. Buenos Aires, Argentina. [abstract] Haemophilia. 2010 Jun; 16(Suppl 4):127.

Brown TM, Lee WC, Joshi AV, Pashos CL. Health-related quality of life and productivity impact in haemophilia patients with inhibitors. Haemophilia. 2009 Jul 1;15(4):911-7.

Knight C, Dano AM, Kennedy-Martin T. A systematic review of the cost-effectiveness of rFVIIa and APCC in the treatment of minor/moderate bleeding episodes for haemophilia patients with inhibitors. Haemophilia. 2009 Mar 1;15(2):405-19.

Lee WC, Joshi AV, Woolford S, Sumner M, Brown TM, Hadker N, Pashos CL. Physicians' preferences towards coagulation factor concentrates in the treatment of haemophilia with inhibitors: a discrete choice experiment. Haemophilia. 2008 May 1;3(14):454-65.

Knight CJ. Health economics of treating hemophilia A with inhibitors. Haemophilia. 2005 Nov 1;11:11-7.

Knight C. Health economics of treating haemophilia a with inhibitors. Haemophilia. 2005 Nov;11(Suppl 1):11-7.

Wight J, Paisley S, Knight C. Immune tolerance induction in patients with haemophilia a with inhibitors: a systematic review. Haemophilia. 2003 Jul;9(4):436-63.

Knight C, Paisley S, Wight J, Jones ML. Economic modelling of different treatment strategies for haemophilia a with high-responding inhibitors. Poster presented at the World Federation of Hemophilia Congress; June 2002. Seville, Spain. [abstract] Haemophilia. 2003 Jul; 9(4):521-40.

Paisley S, Wight J, Currie E, Knight CJ. The management of inhibitors in haemophilia a: introduction and systematic review of current practice. Haemophilia. 2003 Jul;9(4):405-17.

Lloyd Jones M, Wight J, Paisley S, Knight C. Control of bleeding in patients with haemophilia a with inhibitors: a systematic review. Haemophilia. 2003 Jul;9(4):464-520.